Novel oral edaravone attenuates diastolic dysfunction of diabetic cardiomyopathy by activating the Nrf2 signaling pathway
Ling Wang, Yue-Qin Zeng, Juan-Hua Gu, Rui Song, Peng-Hui Cang, Yongxuan Xu, Xiao-Xia Shao, Lijin Pu, Haiyun Luo, Xin‐Fu Zhou
Topics & Concepts
Diabetic cardiomyopathyOxidative stressMalondialdehydeInternal medicineReactive oxygen speciesMedicineEndocrinologyKEAP1Terminal deoxynucleotidyl transferasePharmacologySuperoxide dismutaseTUNEL assayChemistryCardiomyopathyHeart failureBiochemistryTranscription factorImmunohistochemistryGeneCardiovascular Function and Risk FactorsParkinson's Disease Mechanisms and TreatmentsCardiac Ischemia and Reperfusion